Pharma Marketing
GC Therapeutics raises $75 million to advance its revolutionary TFome platform, designed to accelerate the production of iPSC-based therapies by up to 100 times. This breakthrough in cell programming offers faster, high-quality treatments for complex diseases, reshaping the future of regenerative medicine.